Former FDA Cancer Drug Chief Under Consideration to Return
A former FDA cancer drug chief is under consideration to return, as reported by an aggregated news piece sourced from bloomberg.com. Further insights on this potential development remain behind a paywall, leaving many details undisclosed.
1 day ago
2 mins read
